Bladder-only radiotherapy substantially irradiated adjacent pelvic nodes regardless of IMRT technique

Obturator nodes received about 75% of the prescribed bladder dose incidentally, with similar regional exposure from VMAT and fixed-field IMRT.

KEY POINTS

  • The paired planning study used CT datasets from 30 consecutive bladder cancer patients, generating both VMAT and 11-field step-and-shoot IMRT plans on identical anatomy. The bladder received 66 Gy in 33 fractions, with a uniform 1.5-cm PTV margin and daily CBCT verification.
  • Target coverage was essentially identical. PTV V95 was 98.65% with VMAT versus 98.39% with IMRT, D98 was 62.14 versus 62.22 Gy, and no significant differences were seen in target dose, conformity or homogeneity.
  • Incidental nodal irradiation followed a striking anatomical hierarchy: obturator, external iliac, internal iliac and common iliac regions received approximately 75%, 45%, 25% and <5% of prescription dose, respectively. The pattern was highly consistent between VMAT and step-and-shoot IMRT.
  • Obturator exposure was particularly substantial. Median mean dose was approximately 51 Gy bilaterally, with roughly 70–75% of the obturator volume receiving ≥40 Gy and about 53–57% receiving ≥50 Gy depending on technique and side.
  • External iliac nodes received an intermediate dose, with median mean doses around 29–31 Gy, whereas internal iliac mean doses were approximately 17–19 Gy. Common iliac mean doses were only about 2 Gy, reflecting the rapid cranial fall-off from the bladder target.
  • Several regional comparisons reached statistical significance, but absolute differences were generally <1 Gy, inconsistent across nodal basins and not considered clinically meaningful. The authors therefore found no systematic nodal-dose advantage for either delivery technique.
  • VMAT was more delivery-efficient, requiring a median 914 versus 1,123 monitor units (P<.001); IMRT used more monitor units in 29/30 patients. Importantly, the relatively large 1.5-cm PTV margin may have increased incidental nodal exposure compared with contemporary adaptive bladder workflows.

CLINICAL TAKEAWAY

“Bladder-only” radiotherapy is not truly node-sparing: the obturator nodes receive a substantial fraction of therapeutic dose, while the external and internal iliac regions also receive meaningful exposure. This may matter when interpreting bladder-preservation studies and designing trials of elective nodal irradiation, but the study cannot show that incidental dose controls microscopic nodal disease.

SOURCE

Clinical and Translational Radiation Oncology

Browse more research Suggest a correction